On the public citation graph

Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy

https://doi.org/10.1073/pnas.2208436119

0 signed · 87 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1873-3468.12668openalex-snapshot

USP 4 interacts and positively regulates IRF 8 function via K48‐linked deubiquitination in regulatory T cells

inferredcites →https://doi.org/10.1002/1873-3468.12747openalex-snapshot

Multifaceted death receptor 3 signaling—promoting survival and triggering death

inferredcites →https://doi.org/10.1002/eji.201970107openalex-snapshot

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

inferredcites →https://doi.org/10.1016/j.cmet.2019.09.010openalex-snapshot

Roles of Regulatory T Cells in Tissue Pathophysiology and Metabolism

inferredcites →https://doi.org/10.1016/j.immuni.2019.12.002openalex-snapshot

Precursors for Nonlymphoid-Tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATF

inferredcites →https://doi.org/10.1016/j.immuni.2021.03.007openalex-snapshot

Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells

inferredcites →https://doi.org/10.1016/j.it.2011.10.004openalex-snapshot

TNF superfamily in inflammatory disease: translating basic insights

inferredcites →https://doi.org/10.1016/j.jim.2020.112931openalex-snapshot

A method for expansion and retroviral transduction of mouse regulatory T cells

inferredcites →https://doi.org/10.1016/j.ymthe.2019.06.007openalex-snapshot

Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30− Tumors

inferredcites →https://doi.org/10.1038/73136openalex-snapshot

Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

inferredcites →https://doi.org/10.1038/cmi.2015.72openalex-snapshot

Transcription factor IRF8 controls Th1-like regulatory T-cell function

inferredcites →https://doi.org/10.1038/mt.2014.41openalex-snapshot

Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells

inferredcites →https://doi.org/10.1038/ni.3799openalex-snapshot

Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues

inferredcites →https://doi.org/10.1038/nm.3085openalex-snapshot

Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis

inferredcites →https://doi.org/10.1038/nm915openalex-snapshot

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

inferredcites →https://doi.org/10.1038/s41375-019-0625-3openalex-snapshot

Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells

inferredcites →https://doi.org/10.1038/s41418-021-00834-8openalex-snapshot

Lymphotoxin: from the physiology to the regeneration of the thymic function

inferredcites →https://doi.org/10.1038/s41573-019-0041-4openalex-snapshot

Next-generation regulatory T cell therapy

inferredcites →https://doi.org/10.1038/s41587-021-01115-yopenalex-snapshot

Treg engineers take aim at autoimmunity

inferredcites →https://doi.org/10.1053/j.gastro.2009.01.049openalex-snapshot

Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor

inferredcites →https://doi.org/10.1073/pnas.0811556106openalex-snapshot

Heterogeneity of natural Foxp3 + T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity

inferredcites →https://doi.org/10.1073/pnas.2208436119openalex-snapshot

Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy

inferredcites →https://doi.org/10.1093/bioinformatics/btz436openalex-snapshot

snakePipes: facilitating flexible, scalable and integrative epigenomic analysis

inferredcites →https://doi.org/10.1111/ajt.14175openalex-snapshot

Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor

inferredcites →https://doi.org/10.1111/ajt.14185openalex-snapshot

Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection

inferredcites →https://doi.org/10.1111/ajt.15787openalex-snapshot

Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients

inferredcites →https://doi.org/10.1111/j.1600-065x.1994.tb00894.xopenalex-snapshot

Identification of Genes Induced during Apoptosis in T Lymphocytes

inferredcites →https://doi.org/10.1111/j.1600-065x.2008.00633.xopenalex-snapshot

Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease

inferredcites →https://doi.org/10.1126/science.1186068openalex-snapshot

Protein Kinase C-θ Mediates Negative Feedback on Regulatory T Cell Function

inferredcites →https://doi.org/10.1126/science.aau2688openalex-snapshot

T reg cells—the next frontier of cell therapy

inferredcites →https://doi.org/10.1126/sciimmunol.abi4613openalex-snapshot

Transforming growth factor–β1 in regulatory T cell biology

inferredcites →https://doi.org/10.1126/scitranslmed.aaz3866openalex-snapshot

Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells

inferredcites →https://doi.org/10.1146/annurev-immunol-032712-095948openalex-snapshot

Tissue Tregs

inferredcites →https://doi.org/10.1146/annurev-immunol-042718-041717openalex-snapshot

Regulatory T Cells and Human Disease

inferredcites →https://doi.org/10.1172/jci82771openalex-snapshot

Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor

inferredcites →https://doi.org/10.1182/blood-2003-04-1255openalex-snapshot

Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function

inferredcites →https://doi.org/10.1182/blood-2005-11-4567openalex-snapshot

TNF downmodulates the function of human CD4+CD25hi T-regulatory cells

inferredcites →https://doi.org/10.1182/blood-2006-06-027409openalex-snapshot

Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion

inferredcites →https://doi.org/10.1182/blood-2006-09-047332openalex-snapshot

Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease

inferredcites →https://doi.org/10.1182/blood-2009-11-253559openalex-snapshot

Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation

inferredcites →https://doi.org/10.1182/blood-2010-01-265041openalex-snapshot

Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells

inferredcites →https://doi.org/10.1182/blood-2017-11-785865openalex-snapshot

Immune regulatory cell infusion for graft-versus-host disease prevention and therapy

inferredcites →https://doi.org/10.1186/1742-2094-9-112openalex-snapshot

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

inferredcites →https://doi.org/10.1615/critrevimmunol.2020033205openalex-snapshot

Upside and Downside of Tumor Necrosis Factor Blockers for Treatment of Immune/Inflammatory Diseases

inferredcites →https://doi.org/10.18632/oncotarget.15738openalex-snapshot

Dynamic changes in serum cytokine levels and their clinical significance in predicting acute GVHD

inferredcites →https://doi.org/10.18632/oncotarget.15830openalex-snapshot

Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma

inferredcites →https://doi.org/10.3389/fimmu.2017.01125openalex-snapshot

Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of Asthma

inferredcites →https://doi.org/10.3389/fimmu.2019.00043openalex-snapshot

Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity

inferredcites →https://doi.org/10.3390/cells11010021openalex-snapshot

Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing

inferredcites →https://doi.org/10.3892/etm.2021.10125openalex-snapshot

Analysis of therapeutic potential of preclinical models based on DR3/TL1A pathway modulation (Review)

inferredcites →https://doi.org/10.4049/jimmunol.0901582openalex-snapshot

Promoting Immune Responses by LIGHT in the Face of Abundant Regulatory T Cell Inhibition

inferredcites →https://doi.org/10.4049/jimmunol.1201908openalex-snapshot

Cloning, Expression, and Functional Characterization of TL1A-Ig

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4563361openalex-extracted

A Novel Technique for the Construction of Biosensors: CRISPR/Cas13a Activity Regulated by T7 RNA Polymerase Amplification and Peptide Nucleic Acid for the Detection of MMP2

inferred← citeshttps://doi.org/10.1002/advs.76425openalex-snapshot

Oral Prebiotic Polysaccharide Hydrogels Sustaining Colon Antibody Release Alleviate Inflammatory Bowel Disease

inferred← citeshttps://doi.org/10.1002/rmb2.70051openalex-snapshot

Functional Impairment of Activated Regulatory T Cells as a Central Immunological Defect in Endometriosis

inferred← citeshttps://doi.org/10.1007/s00125-023-06076-2openalex-snapshot

Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes

inferred← citeshttps://doi.org/10.1007/s00467-024-06514-2openalex-snapshot

Regulatory cell therapy for kidney transplantation and autoimmune kidney diseases

inferred← citeshttps://doi.org/10.1007/s11033-026-12310-yopenalex-snapshot

Precision Immunoregulation in transplantation: The rise of engineered Treg therapies

inferred← citeshttps://doi.org/10.1007/s12032-024-02300-0openalex-snapshot

Selective targeting or reprogramming of intra-tumoral Tregs

inferred← citeshttps://doi.org/10.1007/s13577-025-01280-1openalex-snapshot

Regulatory T cells in cancer anti-PD-(L)1 therapy

inferred← citeshttps://doi.org/10.1007/s44174-025-00490-3openalex-snapshot

Biosensors for Human Cell Analysis: Immune Cell Dynamics and Diagnostic Capabilities

inferred← citeshttps://doi.org/10.1016/j.intimp.2024.112360openalex-snapshot

Anti-TL1A monoclonal antibody modulates the dysregulation of Th1/Th17 cells and attenuates granuloma formation in sarcoidosis by inhibiting the PI3K/AKT signaling pathway

inferred← citeshttps://doi.org/10.1016/j.it.2023.04.005openalex-snapshot

Engineered Treg cells as putative therapeutics against inflammatory diseases and beyond

inferred← citeshttps://doi.org/10.1016/j.it.2025.12.001openalex-snapshot

Tissue-resident regulatory T cells: modulators of local immunity

inferred← citeshttps://doi.org/10.1016/j.ymthe.2026.01.002openalex-snapshot

Engineered CD40-biosensor-expressing Treg cells as a cell therapy approach for inflammatory diseases

inferred← citeshttps://doi.org/10.1016/j.ymthe.2026.05.017openalex-snapshot

Engineering human T cells with antigen receptors for immune regulation in autoimmune disease and transplantation

inferred← citeshttps://doi.org/10.1016/s2665-9913(24)00377-1openalex-snapshot

CAR T-cell therapy in autoimmune diseases: where are we and where are we going?

inferred← citeshttps://doi.org/10.1038/s41467-024-50806-yopenalex-snapshot

Tregs delivered post-myocardial infarction adopt an injury-specific phenotype promoting cardiac repair via macrophages in mice

inferred← citeshttps://doi.org/10.1038/s41573-024-01089-xopenalex-snapshot

Harnessing the biology of regulatory T cells to treat disease

inferred← citeshttps://doi.org/10.1038/s41573-025-01242-0openalex-snapshot

Advances in the treatment of systemic lupus erythematosus

inferred← citeshttps://doi.org/10.1038/s41573-025-01268-4openalex-snapshot

Microsystem technologies for accelerating the discovery and translation of immunotherapies

inferred← citeshttps://doi.org/10.1038/s41577-023-00970-xopenalex-snapshot

Therapeutic induction of antigen-specific immune tolerance

inferred← citeshttps://doi.org/10.1073/pnas.2215271119openalex-snapshot

Targeting inflammation to improve regulatory T cell therapy for immunopathologies

inferred← citeshttps://doi.org/10.1073/pnas.2320482121openalex-snapshot

Inflammation-oriented montmorillonite adjuvant enhanced oral delivery of anti-TNF-α nanobody against inflammatory bowel disease

inferred← citeshttps://doi.org/10.1080/21645515.2025.2538350openalex-snapshot

Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases

inferred← citeshttps://doi.org/10.1093/humrep/deaf054openalex-snapshot

Adoptive transfer of regulatory T cells inhibits the progression of endometriosis-like lesions in regulatory T-cell-depleted mice

inferred← citeshttps://doi.org/10.1093/immadv/ltad007openalex-snapshot

Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective

inferred← citeshttps://doi.org/10.1093/jleuko/qiag067openalex-snapshot

Beyond suppression: the plasticity, dysfunction, and therapeutic reprogramming of regulatory T cells in inflammatory bowel disease

inferred← citeshttps://doi.org/10.1111/imr.13254openalex-snapshot

Eras of designer Tregs: Harnessing synthetic biology for immune suppression

inferred← citeshttps://doi.org/10.1146/annurev-immunol-082924-092651openalex-snapshot

Tissue Regulatory T Cells

inferred← citeshttps://doi.org/10.1186/s41232-024-00327-4openalex-snapshot

Designer cell therapy for tissue regeneration

inferred← citeshttps://doi.org/10.3389/fimmu.2025.1511671openalex-snapshot

T-regulatory cells for the treatment of autoimmune diseases

inferred← citeshttps://doi.org/10.3389/fimmu.2025.1581093openalex-snapshot

Revisiting Tregs in cancer and beyond: immunological control and therapeutic potential

inferred← citeshttps://doi.org/10.3389/fsci.2026.1792210openalex-snapshot

Regulatory T cells: master orchestrators of immune tolerance and tissue homeostasis

inferred← citeshttps://doi.org/10.3390/ijms262110340openalex-snapshot

Regulatory T Cell-Based Adoptive Cell Therapy in Autoimmunity

inferred← citeshttps://doi.org/10.4285/ctr.24.0065openalex-snapshot

Current status of xenotransplantation from an immunobiological standpoint

showing the first 34 of 35

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.